$SVRA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Savara Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Savara Inc. Get notifications about new insider transactions in Savara Inc for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 09 2015 | MSTX | Mast Therapeutics, ... | Greenleaf Peter | Director | Option Exercise | A | 0.45 | 37,794 | 17,007 | 37,794 | |
Nov 09 2015 | MSTX | Mast Therapeutics, ... | Greenleaf Peter | Director | Option Exercise | A | 0.45 | 64,791 | 29,156 | 64,791 | |
Nov 02 2015 | MSTX | Mast Therapeutics, ... | Pauls Matthew | Director | Option Exercise | A | 0.48 | 37,794 | 18,141 | 37,794 | |
Nov 02 2015 | MSTX | Mast Therapeutics, ... | Pauls Matthew | Director | Option Exercise | A | 0.48 | 64,791 | 31,100 | 64,791 | |
Jun 12 2015 | MSTX | Mast Therapeutics, ... | Gorgas Gregory D. | Senior VP, Commerci ... | Option Exercise | A | 0.50 | 417,100 | 208,550 | 417,100 | |
Jun 12 2015 | MSTX | Mast Therapeutics, ... | EMANUELE ROBERT MARTIN | Senior VP, Developm ... | Option Exercise | A | 0.50 | 291,500 | 145,750 | 291,500 | |
Jun 12 2015 | MSTX | Mast Therapeutics, ... | Shuster Lewis | Director | Option Exercise | A | 0.50 | 82,963 | 41,482 | 82,963 | |
Jun 12 2015 | MSTX | Mast Therapeutics, ... | RAMSAY DAVID A | Director | Option Exercise | A | 0.50 | 82,963 | 41,482 | 82,963 | |
Jun 12 2015 | MSTX | Mast Therapeutics, ... | Roberts Brandi | Chief Financial Off ... | Option Exercise | A | 0.50 | 444,400 | 222,200 | 444,400 | |
Jun 12 2015 | MSTX | Mast Therapeutics, ... | Parsley Edwin L. | Chief Medical Offic ... | Option Exercise | A | 0.50 | 555,850 | 277,925 | 555,850 | |
Jun 12 2015 | MSTX | Mast Therapeutics, ... | Culley Brian M | CEO and Director | Option Exercise | A | 0.50 | 888,900 | 444,450 | 888,900 | |
Jun 12 2015 | MSTX | Mast Therapeutics, ... | LIEF JACK | Director | Option Exercise | A | 0.50 | 82,963 | 41,482 | 82,963 | |
Jun 12 2015 | MSTX | Mast Therapeutics, ... | DITTRICH HOWARD | Director | Option Exercise | A | 0.50 | 82,963 | 41,482 | 82,963 | |
Mar 30 2015 | MSTX | Mast Therapeutics, ... | Roberts Brandi | Chief Financial Off ... | Buy | P | 0.50 | 18,000 | 8,950 | 38,000 | 20 K to 38 K (+90.00 %) |
Mar 30 2015 | MSTX | Mast Therapeutics, ... | Roberts Brandi | Chief Financial Off ... | Buy | P | 0.50 | 20,000 | 10,032 | 20,000 | 0 to 20 K |
Jan 02 2015 | MSTX | Mast Therapeutics, ... | Gorgas Gregory D. | Senior VP, Commerci ... | Option Exercise | A | 0.58 | 622,800 | 361,224 | 622,800 | |
Jan 02 2015 | MSTX | Mast Therapeutics, ... | EMANUELE ROBERT MARTIN | Senior VP, Developm ... | Option Exercise | A | 0.58 | 500,250 | 290,145 | 500,250 | |
Jan 02 2015 | MSTX | Mast Therapeutics, ... | Culley Brian M | CEO and Director | Option Exercise | A | 0.58 | 2,100,550 | 1,218,319 | 2,100,550 | |
Jan 02 2015 | MSTX | Mast Therapeutics, ... | Keran Patrick L | President & COO | Option Exercise | A | 0.58 | 2,100,550 | 1,218,319 | 2,100,550 | |
Jan 02 2015 | MSTX | Mast Therapeutics, ... | Roberts Brandi | Chief Financial Off ... | Option Exercise | A | 0.58 | 722,800 | 419,224 | 722,800 | |
Jan 02 2015 | MSTX | Mast Therapeutics, ... | Parsley Edwin L. | Chief Medical Offic ... | Option Exercise | A | 0.58 | 938,300 | 544,214 | 938,300 | |
Oct 02 2014 | MSTX | Mast Therapeutics, ... | Parsley Edwin L. | Chief Medical Offic ... | Option Exercise | A | 0.59 | 600,000 | 354,000 | 600,000 | |
Jun 20 2014 | MSTX | Mast Therapeutics, ... | Shuster Lewis | Director | Option Exercise | A | 0.65 | 46,609 | 30,296 | 46,609 | |
Jun 20 2014 | MSTX | Mast Therapeutics, ... | Gorgas Gregory D. | Senior VP, Commerci ... | Option Exercise | A | 0.65 | 320,650 | 208,423 | 320,650 | |
Jun 20 2014 | MSTX | Mast Therapeutics, ... | Roberts Brandi | Chief Financial Off ... | Option Exercise | A | 0.65 | 336,600 | 218,790 | 336,600 | |
Jun 20 2014 | MSTX | Mast Therapeutics, ... | RAMSAY DAVID A | Director | Option Exercise | A | 0.65 | 46,609 | 30,296 | 46,609 | |
Jun 20 2014 | MSTX | Mast Therapeutics, ... | Culley Brian M | CEO and Director | Option Exercise | A | 0.65 | 1,114,250 | 724,263 | 1,114,250 | |
Jun 20 2014 | MSTX | Mast Therapeutics, ... | EMANUELE ROBERT MARTIN | Senior VP, Developm ... | Option Exercise | A | 0.65 | 285,400 | 185,510 | 285,400 | |
Jun 20 2014 | MSTX | Mast Therapeutics, ... | Keran Patrick L | President & COO | Option Exercise | A | 0.65 | 1,114,250 | 724,263 | 1,114,250 | |
Jun 20 2014 | MSTX | Mast Therapeutics, ... | LIEF JACK | Director | Option Exercise | A | 0.65 | 46,609 | 30,296 | 46,609 | |
Jun 20 2014 | MSTX | Mast Therapeutics, ... | Vetticaden Santosh | Chief Medical Offic ... | Option Exercise | A | 0.65 | 529,300 | 344,045 | 529,300 | |
Jun 20 2014 | MSTX | Mast Therapeutics, ... | DITTRICH HOWARD | Director | Option Exercise | A | 0.65 | 46,609 | 30,296 | 46,609 | |
Jun 20 2014 | MSTX | Mast Therapeutics, ... | DITTRICH HOWARD | Director | Option Exercise | A | 0.65 | 46,609 | 30,296 | 46,609 | |
Jan 03 2014 | MSTX | Mast Therapeutics, ... | Gorgas Gregory D. | Senior VP, Commerci ... | Option Exercise | A | 0.47 | 49,500 | 23,265 | 49,500 | |
Jan 03 2014 | MSTX | Mast Therapeutics, ... | Vetticaden Santosh | Chief Medical Offic ... | Option Exercise | A | 0.47 | 295,100 | 138,697 | 295,100 | |
Jan 03 2014 | MSTX | Mast Therapeutics, ... | EMANUELE ROBERT MARTIN | Senior VP, Developm ... | Option Exercise | A | 0.47 | 115,900 | 54,473 | 115,900 | |
Jan 03 2014 | MSTX | Mast Therapeutics, ... | Keran Patrick L | President & COO | Option Exercise | A | 0.47 | 650,300 | 305,641 | 650,300 | |
Jan 03 2014 | MSTX | Mast Therapeutics, ... | Culley Brian M | CEO and Director | Option Exercise | A | 0.47 | 650,300 | 305,641 | 650,300 | |
Jan 03 2014 | MSTX | Mast Therapeutics, ... | Roberts Brandi | Chief Financial Off ... | Option Exercise | A | 0.47 | 101,200 | 47,564 | 101,200 | |
Jun 21 2013 | MSTX | Mast Therapeutics, ... | LIEF JACK | Director | Option Exercise | A | 0.50 | 62,451 | 31,226 | 62,451 | |
Jun 21 2013 | MSTX | Mast Therapeutics, ... | Shuster Lewis | Director | Option Exercise | A | 0.50 | 62,451 | 31,226 | 62,451 | |
Jun 21 2013 | MSTX | Mast Therapeutics, ... | Roberts Brandi | Chief Financial Off ... | Option Exercise | A | 0.50 | 301,250 | 150,625 | 301,250 | |
Jun 21 2013 | MSTX | Mast Therapeutics, ... | Keran Patrick L | President & COO | Option Exercise | A | 0.50 | 907,300 | 453,650 | 907,300 | |
Jun 21 2013 | MSTX | Mast Therapeutics, ... | Culley Brian M | CEO and Director | Option Exercise | A | 0.50 | 907,300 | 453,650 | 907,300 | |
Jun 21 2013 | MSTX | Mast Therapeutics, ... | Vetticaden Santosh | Chief Medical Offic ... | Option Exercise | A | 0.50 | 125,000 | 62,500 | 125,000 | |
Jun 21 2013 | MSTX | Mast Therapeutics, ... | Gorgas Gregory D. | Senior VP, Commerci ... | Option Exercise | A | 0.50 | 292,500 | 146,250 | 292,500 | |
Jun 21 2013 | MSTX | Mast Therapeutics, ... | LOVE TED W | Director | Option Exercise | A | 0.50 | 62,451 | 31,226 | 62,451 | |
Jun 21 2013 | MSTX | Mast Therapeutics, ... | RAMSAY DAVID A | Director | Option Exercise | A | 0.50 | 62,451 | 31,226 | 62,451 | |
May 31 2013 | MSTX | Mast Therapeutics, ... | EMANUELE ROBERT MARTIN | Senior VP, Developm ... | Grant | A | 0.00 | 52,543 | 0 | 294,598 | 242.1 K to 294.6 K (+21.71 %) |
Jan 18 2013 | MSTX | Mast Therapeutics, ... | EMANUELE ROBERT MARTIN | Senior VP, Developm ... | Sell | J | 0.00 | 305,608 | 306 | 242,055 | 547.7 K to 242.1 K (-55.80 %) |
Jan 03 2013 | MSTX | Mast Therapeutics, ... | Gorgas Gregory D. | Senior VP, Commerci ... | Option Exercise | A | 0.59 | 58,250 | 34,368 | 58,250 | |
Jan 03 2013 | MSTX | Mast Therapeutics, ... | Keran Patrick L | President & COO | Option Exercise | A | 0.59 | 138,650 | 81,804 | 138,650 | |
Jan 03 2013 | MSTX | Mast Therapeutics, ... | Roberts Brandi | Chief Financial Off ... | Option Exercise | A | 0.59 | 75,750 | 44,693 | 75,750 | |
Jan 03 2013 | MSTX | Mast Therapeutics, ... | Culley Brian M | CEO and Director | Option Exercise | A | 0.59 | 138,650 | 81,804 | 138,650 | |
Sep 07 2012 | MSTX | Mast Therapeutics, ... | LOVE TED W | Director | Option Exercise | A | 0.69 | 14,171 | 9,778 | 14,171 | |
Sep 07 2012 | MSTX | Mast Therapeutics, ... | LOVE TED W | Director | Option Exercise | A | 0.69 | 18,895 | 13,038 | 18,895 | |
Sep 05 2012 | MSTX | Mast Therapeutics, ... | Vetticaden Santosh | Chief Medical Offic ... | Option Exercise | A | 0.69 | 600,000 | 414,000 | 600,000 | |
Jul 30 2012 | MSTX | Mast Therapeutics, ... | Shuster Lewis | Director | Option Exercise | A | 0.66 | 27,310 | 18,025 | 27,310 | |
Jul 30 2012 | MSTX | Mast Therapeutics, ... | RAMSAY DAVID A | Director | Option Exercise | A | 0.66 | 27,310 | 18,025 | 27,310 | |
Jul 30 2012 | MSTX | Mast Therapeutics, ... | LIEF JACK | Director | Option Exercise | A | 0.66 | 27,310 | 18,025 | 27,310 | |
May 14 2012 | MSTX | Mast Therapeutics, ... | RAMSAY DAVID A | Director | Buy | P | 0.54 | 50,000 | 26,965 | 100,000 | 50 K to 100 K (+100.00 %) |
May 10 2012 | MSTX | Mast Therapeutics, ... | RAMSAY DAVID A | Director | Buy | P | 0.57 | 40,000 | 22,612 | 50,000 | 10 K to 50 K (+400.00 %) |
May 10 2012 | MSTX | Mast Therapeutics, ... | RAMSAY DAVID A | Director | Buy | P | 0.55 | 10,000 | 5,500 | 10,000 | 0 to 10 K |
Mar 15 2012 | MSTX | Mast Therapeutics, ... | Culley Brian M | CEO and Director | Buy | P | 0.59 | 20,500 | 12,103 | 34,500 | 14 K to 34.5 K (+146.43 %) |
Mar 14 2012 | MSTX | Mast Therapeutics, ... | Culley Brian M | CEO and Director | Buy | P | 0.58 | 14,000 | 8,144 | 14,000 | 0 to 14 K |
Dec 19 2011 | MSTX | Mast Therapeutics, ... | EMANUELE ROBERT MARTIN | Senior VP, Developm ... | Sell | S | 0.60 | 41,000 | 24,432 | 547,663 | 588.7 K to 547.7 K (-6.96 %) |
Dec 09 2011 | MSTX | Mast Therapeutics, ... | Roberts Brandi | Vice President, Fin ... | Option Exercise | A | 0.60 | 140,000 | 84,000 | 140,000 | |
Dec 09 2011 | MSTX | Mast Therapeutics, ... | Gorgas Gregory D. | Senior VP, Commerci ... | Option Exercise | A | 0.60 | 160,000 | 96,000 | 160,000 | |
Dec 09 2011 | MSTX | Mast Therapeutics, ... | Keran Patrick L | President & COO | Option Exercise | A | 0.60 | 425,000 | 255,000 | 425,000 | |
Dec 09 2011 | MSTX | Mast Therapeutics, ... | Culley Brian M | Chief Executive Off ... | Option Exercise | A | 0.60 | 425,000 | 255,000 | 425,000 | |
Jul 22 2011 | MSTX | Mast Therapeutics, ... | Gorgas Gregory D. | Senior VP, Commerci ... | Option Exercise | A | 3.44 | 100,000 | 344,000 | 100,000 | |
Jul 08 2011 | MSTX | Mast Therapeutics, ... | Keran Patrick L | President and COO | Option Exercise | A | 3.26 | 250,000 | 815,000 | 250,000 | |
Jul 08 2011 | MSTX | Mast Therapeutics, ... | Culley Brian M | Chief Executive Off ... | Option Exercise | A | 3.26 | 250,000 | 815,000 | 250,000 | |
Jun 17 2011 | MSTX | Mast Therapeutics, ... | RAMSAY DAVID A | Director | Option Exercise | A | 2.35 | 10,480 | 24,628 | 10,480 | |
Jun 17 2011 | MSTX | Mast Therapeutics, ... | RAMSAY DAVID A | Director | Option Exercise | A | 2.35 | 10,480 | 24,628 | 10,480 | |
Jun 17 2011 | MSTX | Mast Therapeutics, ... | LIEF JACK | Director | Option Exercise | A | 2.35 | 15,139 | 35,577 | 15,139 | |
Jun 17 2011 | MSTX | Mast Therapeutics, ... | Roberts Brandi | Vice President, Fin ... | Option Exercise | A | 2.35 | 85,000 | 199,750 | 85,000 | |
Jun 17 2011 | MSTX | Mast Therapeutics, ... | Shuster Lewis | Director | Option Exercise | A | 2.35 | 1,746 | 4,103 | 1,746 | |
Jun 17 2011 | MSTX | Mast Therapeutics, ... | Shuster Lewis | Director | Option Exercise | A | 2.35 | 10,480 | 24,628 | 10,480 | |
Jun 17 2011 | MSTX | Mast Therapeutics, ... | Shuster Lewis | Director | Option Exercise | A | 2.35 | 10,480 | 24,628 | 10,480 | |
Jun 03 2011 | MSTX | Mast Therapeutics, ... | Culley Brian M | Chief Executive Off ... | Sell | S | 2.44 | 5,000 | 12,200 | 0 | 5 K to 0 (-100.00 %) |
Feb 03 2011 | MSTX | Mast Therapeutics, ... | Keran Patrick L | President & COO | Option Exercise | A | 2.29 | 100,000 | 229,000 | 100,000 | |
Feb 03 2011 | MSTX | Mast Therapeutics, ... | Culley Brian M | Chief Executive Off ... | Option Exercise | A | 2.29 | 100,000 | 229,000 | 100,000 | |
Jul 01 2010 | MSTX | Mast Therapeutics, ... | GOLDBERG MICHAEL M | Director | Option Exercise | A | 1.63 | 4,000 | 6,520 | 4,000 | |
Jul 01 2010 | MSTX | Mast Therapeutics, ... | Rowinsky Eric K | Director | Option Exercise | A | 1.63 | 4,000 | 6,520 | 4,000 | |
Jul 01 2010 | MSTX | Mast Therapeutics, ... | PYKETT MARK JEROME | Director | Option Exercise | A | 1.63 | 4,000 | 6,520 | 4,000 | |
Jul 01 2010 | MSTX | Mast Therapeutics, ... | LIEF JACK | Director | Option Exercise | A | 1.63 | 4,000 | 6,520 | 4,000 | |
Jul 01 2010 | MSTX | Mast Therapeutics, ... | Kostas Odysseas D | Director | Option Exercise | A | 1.63 | 4,000 | 6,520 | 4,000 | |
May 27 2010 | MSTX | Mast Therapeutics, ... | Culley Brian M | Chief Executive Off ... | Buy | P | 1.89 | 5,000 | 9,450 | 5,000 | 0 to 5 K |
Feb 03 2010 | MSTX | Mast Therapeutics, ... | PYKETT MARK JEROME | Director | Option Exercise | A | 0.32 | 100,000 | 32,000 | 100,000 | |
Feb 03 2010 | MSTX | Mast Therapeutics, ... | PYKETT MARK JEROME | Director | Option Exercise | A | 0.32 | 100,000 | 32,000 | 100,000 | |
Feb 03 2010 | MSTX | Mast Therapeutics, ... | Rowinsky Eric K | Director | Option Exercise | A | 0.32 | 100,000 | 32,000 | 100,000 | |
Feb 03 2010 | MSTX | Mast Therapeutics, ... | Rowinsky Eric K | Director | Option Exercise | A | 0.32 | 100,000 | 32,000 | 100,000 | |
Feb 03 2010 | MSTX | Mast Therapeutics, ... | GOLDBERG MICHAEL M | Director | Option Exercise | A | 0.32 | 100,000 | 32,000 | 100,000 | |
Feb 03 2010 | MSTX | Mast Therapeutics, ... | GOLDBERG MICHAEL M | Director | Option Exercise | A | 0.32 | 100,000 | 32,000 | 100,000 | |
Feb 03 2010 | MSTX | Mast Therapeutics, ... | Keran Patrick L | President, COO and ... | Option Exercise | A | 0.32 | 1,600,000 | 512,000 | 1,600,000 | |
Feb 03 2010 | MSTX | Mast Therapeutics, ... | LIEF JACK | Director | Option Exercise | A | 0.32 | 100,000 | 32,000 | 100,000 | |
Feb 03 2010 | MSTX | Mast Therapeutics, ... | LIEF JACK | Director | Option Exercise | A | 0.32 | 100,000 | 32,000 | 100,000 | |
Feb 03 2010 | MSTX | Mast Therapeutics, ... | Culley Brian M | Chief Executive Off ... | Option Exercise | A | 0.32 | 1,600,000 | 512,000 | 1,600,000 | |
Feb 03 2010 | MSTX | Mast Therapeutics, ... | Kostas Odysseas D | Director | Option Exercise | A | 0.32 | 33,332 | 10,666 | 33,332 | |
Feb 03 2010 | MSTX | Mast Therapeutics, ... | Kostas Odysseas D | Director | Option Exercise | A | 0.32 | 100,000 | 32,000 | 100,000 | |
Jul 23 2009 | MSTX | Mast Therapeutics, ... | Keran Patrick L | VP, Legal and Gener ... | Option Exercise | A | 0.13 | 1,700,000 | 221,000 | 1,700,000 | |
Jul 23 2009 | MSTX | Mast Therapeutics, ... | Keran Patrick L | VP, Legal and Gener ... | Option Exercise | D | 0.09 | 850,000 | 77,435 | 0 | |
Jul 23 2009 | MSTX | Mast Therapeutics, ... | Culley Brian M | SVP & Chief Busines ... | Option Exercise | A | 0.13 | 1,700,000 | 221,000 | 1,700,000 | |
Jul 23 2009 | MSTX | Mast Therapeutics, ... | Culley Brian M | SVP & Chief Busines ... | Option Exercise | D | 0.09 | 1,200,000 | 109,320 | 0 | |
Feb 03 2009 | MSTX | Mast Therapeutics, ... | Yelmene Michele | VP, Regulatory & QA | Option Exercise | A | 0.09 | 450,000 | 40,995 | 450,000 | |
Feb 03 2009 | MSTX | Mast Therapeutics, ... | Erwin Mark E. | SVP, Operations | Option Exercise | A | 0.09 | 650,000 | 59,215 | 650,000 | |
Feb 03 2009 | MSTX | Mast Therapeutics, ... | Keran Patrick L | VP, Legal and Gener ... | Option Exercise | A | 0.09 | 850,000 | 77,435 | 850,000 | |
Feb 03 2009 | MSTX | Mast Therapeutics, ... | Culley Brian M | SVP & Chief Busines ... | Option Exercise | A | 0.09 | 1,200,000 | 109,320 | 1,200,000 | |
Jul 08 2008 | MSTX | Mast Therapeutics, ... | Denner Alexander J | Director | Option Exercise | A | 0.37 | 50,000 | 18,500 | 150,000 | |
Jul 02 2008 | MSTX | Mast Therapeutics, ... | PYKETT MARK JEROME | Director | Option Exercise | A | 0.37 | 50,000 | 18,500 | 50,000 | |
Jul 02 2008 | MSTX | Mast Therapeutics, ... | Rowinsky Eric K | Director | Option Exercise | A | 0.37 | 50,000 | 18,500 | 50,000 | |
Jul 02 2008 | MSTX | Mast Therapeutics, ... | GOLDBERG MICHAEL M | Director | Option Exercise | A | 0.37 | 50,000 | 18,500 | 50,000 | |
Jul 02 2008 | MSTX | Mast Therapeutics, ... | LIEF JACK | Director | Option Exercise | A | 0.37 | 50,000 | 18,500 | 50,000 | |
May 16 2008 | MSTX | Mast Therapeutics, ... | ROBBINS JOAN M | CSO, Sr. VP | Buy | P | 0.43 | 5,000 | 2,150 | 10,000 | 5 K to 10 K (+100.00 %) |
May 16 2008 | MSTX | Mast Therapeutics, ... | ROBBINS JOAN M | CSO, Sr. VP | Buy | P | 0.44 | 5,000 | 2,200 | 5,000 | 0 to 5 K |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.50 | 2,000 | 1,000 | 4,395,000 | 4.4 M to 4.4 M (+0.05 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.51 | 3,000 | 1,530 | 4,393,000 | 4.4 M to 4.4 M (+0.07 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.42 | 2,000 | 840 | 4,390,000 | 4.4 M to 4.4 M (+0.05 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.43 | 3,000 | 1,290 | 4,388,000 | 4.4 M to 4.4 M (+0.07 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.42 | 5,000 | 2,100 | 4,385,000 | 4.4 M to 4.4 M (+0.11 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Sell | S | 0.59 | 3,000 | 1,770 | 4,380,000 | 4.4 M to 4.4 M (-0.07 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Sell | S | 0.60 | 100 | 60 | 4,383,000 | 4.4 M to 4.4 M (0.00 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Sell | S | 0.60 | 900 | 541 | 4,383,100 | 4.4 M to 4.4 M (-0.02 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 2.63 | 1,000 | 2,630 | 4,384,000 | 4.4 M to 4.4 M (+0.02 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Sell | S | 2.82 | 1,000 | 2,820 | 4,383,000 | 4.4 M to 4.4 M (-0.02 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 3.15 | 1,000 | 3,150 | 4,384,000 | 4.4 M to 4.4 M (+0.02 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 4.36 | 1,000 | 4,360 | 4,383,000 | 4.4 M to 4.4 M (+0.02 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 4.47 | 1,000 | 4,470 | 4,382,000 | 4.4 M to 4.4 M (+0.02 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 5.15 | 1,000 | 5,150 | 4,381,000 | 4.4 M to 4.4 M (+0.02 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Sell | S | 4.29 | 2,000 | 8,580 | 4,380,000 | 4.4 M to 4.4 M (-0.05 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 3.87 | 1,000 | 3,870 | 4,382,000 | 4.4 M to 4.4 M (+0.02 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 3.86 | 100 | 386 | 4,381,000 | 4.4 M to 4.4 M (0.00 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 3.86 | 900 | 3,474 | 4,380,900 | 4.4 M to 4.4 M (+0.02 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Sell | S | 3.22 | 1,200 | 3,864 | 4,380,000 | 4.4 M to 4.4 M (-0.03 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Sell | S | 3.16 | 3,800 | 12,008 | 4,381,200 | 4.4 M to 4.4 M (-0.09 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Sell | S | 1.50 | 3,000 | 4,500 | 4,385,000 | 4.4 M to 4.4 M (-0.07 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.86 | 1,800 | 1,548 | 4,388,000 | 4.4 M to 4.4 M (+0.04 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.93 | 100 | 93 | 4,386,200 | 4.4 M to 4.4 M (0.00 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.93 | 400 | 372 | 4,386,100 | 4.4 M to 4.4 M (+0.01 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.93 | 100 | 93 | 4,385,700 | 4.4 M to 4.4 M (0.00 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.93 | 400 | 372 | 4,385,600 | 4.4 M to 4.4 M (+0.01 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.93 | 1,500 | 1,395 | 4,385,200 | 4.4 M to 4.4 M (+0.03 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.93 | 500 | 465 | 4,383,700 | 4.4 M to 4.4 M (+0.01 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.93 | 100 | 93 | 4,383,200 | 4.4 M to 4.4 M (0.00 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.93 | 100 | 93 | 4,383,100 | 4.4 M to 4.4 M (0.00 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 1.19 | 700 | 833 | 4,383,000 | 4.4 M to 4.4 M (+0.02 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 1.19 | 2,300 | 2,737 | 4,382,300 | 4.4 M to 4.4 M (+0.05 %) |
Apr 15 2008 | MSTX | Mast Therapeutics, ... | PYKETT MARK JEROME | Director | Buy | P | 2.08 | 500 | 1,040 | 8,000 | 7.5 K to 8 K (+6.67 %) |
Apr 07 2008 | MSTX | Mast Therapeutics, ... | Bagnall Mark | CFO & Executive Vic ... | Option Exercise | A | 0.52 | 500,000 | 260,000 | 500,000 |